> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Info Collection on Drug Maker Emergency Plans
- URL: https://www.fdaweb.com/info-collection-on-drug-maker-emergency-plans/
- Published: 2019-10-28T12:00:00.000Z
- Updated: 2026-09-15T01:59:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5145351

*Federal Register* notice: FDA is seeking comments on an information collection extension entitled “Planning for the Effects of High Absenteeism To Ensure Availability of Medically Necessary Drug Products” (OMB Control Number 0910-0675). The collection supports guidance recommendations intended to encourage manufacturers of drug and therapeutic biological products, and any raw materials and components used in those products, to develop a written emergency plan for maintaining an adequate supply of medically necessary drug products during an emergency that results in high employee absenteeism. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-10-25/pdf/2019-23272.pdf?ref=fdaweb.com).